Mumbai, January 31, 2025 – Aster DM Healthcare Limited (BSE: 540975 | NSE: ASTERDM) has released its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. The company has also declared an interim dividend for FY25.
Key Financial Highlights (Standalone)
Quarter Ended December 31, 2024 (INR crores)
Particulars
Q3 FY25
Q2 FY25
Q3 FY24
Revenue from Operations
576.32
604.68
524.50
Other Income
37.29
46.74
13.33
Total Income
613.61
651.42
537.83
Total Expenses
522.15
531.59
484.64
Profit Before Tax (PBT)
68.33
119.83
53.19
Net Profit
49.82
89.84
53.19
Basic EPS (INR)
1.00
1.80
1.07
Nine Months Ended December 31, 2024
Particulars
9M FY25
9M FY24
Revenue from Operations
1,746.62
1,490.94
Other Income
5,103.54
45.30
Total Income
7,480.16
1,536.24
Total Expenses
1,574.08
1,373.54
Profit Before Tax (PBT)
6,225.65
162.70
Net Profit
6,147.90
165.07
Key Financial Highlights (Consolidated)
Quarter Ended December 31, 2024
Particulars
Q3 FY25
Q2 FY25
Q3 FY24
Revenue from Operations
1,094.81
1,086.04
954.67
Other Income
32.89
25.24
9.20
Total Income
1,127.70
1,111.28
963.87
Total Expenses
953.61
960.43
884.74
Profit Before Tax (PBT)
101.88
158.65
76.61
Net Profit
64.39
105.76
65.37
Interim Dividend Declared
The Board declared an interim dividend of ₹4 per share (face value ₹10).
Record Date: February 10, 2025.
The dividend will be paid within 30 days of declaration.
Management Commentary
Aster DM Healthcare continues to expand its presence and maintain operational efficiency despite industry headwinds. The company's significant revenue growth in the nine-month period underscores its resilience and strong market positioning.
Outlook
With strategic expansion and a robust financial performance, the company aims to enhance shareholder value while navigating industry challenges.
